1 completed, 1 not yet recruiting. 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 4 | 1 | Not yet recruiting 1 |
Follow Nerandomilast 18 mg - adult formulation: new trials by email Literature Review of Nerandomilast 18 mg - adult formulation trials Research Report on Nerandomilast 18 mg - adult formulation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| This is a Trial Designed to Evaluate the Combination of Nerandomilast With Mycophenolate Across a Wide Variety of Pulmonary Fibrosis Subtypes, With the Aim of Providing Clinicians With Assurance That This is an Appropriate Therapeutic Combination. Nerandomilast 18 mg - adult formulation - Pulmonary Fibrosis, Interstitial Lung Disease (ILD) | Phase 4 | Not yet recruiting | University of British Columbia | 120 | 2026-06-01 | 2026-05-11 |
| A Study in Healthy People to Compare 2 Different Formulations of Nerandomilast Tablets When Taken With or Without Food Nerandomilast 18 mg - adult formulation, Nerandomilast 1 mg - paediatric formulation - Healthy | Phase 1 | Completed | Boehringer Ingelheim | 15 | 2024-10-15 | 2026-01-08 |
Lung Diseases, Interstitial (1) · Pulmonary Fibrosis (1)
Boehringer Ingelheim (1) · University of British Columbia (1)
Germany (1)